haloperidol has been researched along with Cancer of Liver in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Feng, H; Huang, D; Khan, H; Ni, Z; Niu, Y; Shi, G; Wu, X; Xing, Y | 1 |
| Bai, T; Sun, Y; Wang, S; Wang, W; Zhao, Y; Zhu, R | 1 |
| Azuara, ML; Barcia, E; Negro, S; Reyes, R; Sánchez, Y | 1 |
| Gurkalo, VK; Zabezhinskiĭ, MA | 1 |
| Amthauer, H; Furth, C; Grosser, OS; Pech, M; Ricke, J; Ruf, J; Ulrich, G | 1 |
| Munkelt, BE; Wolf, CF | 1 |
| Schoental, R | 1 |
7 other study(ies) available for haloperidol and Cancer of Liver
| Article | Year |
|---|---|
Combination of curcumin with N-n-butyl haloperidol iodide inhibits hepatocellular carcinoma malignant proliferation by downregulating enhancer of zeste homolog 2 (EZH2) - lncRNA H19 to silence Wnt/β-catenin signaling.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Curcumin; Enhancer of Zeste Homolog 2 Protein; Gene Expression Regulation, Neoplastic; Haloperidol; Humans; Liver Neoplasms; Mice, Nude; RNA, Long Noncoding; Wnt Signaling Pathway; Xenograft Model Antitumor Assays | 2021 |
Haloperidol, a sigma receptor 1 antagonist, promotes ferroptosis in hepatocellular carcinoma cells.
Topics: Apoptosis; Carcinoma, Hepatocellular; Cell Survival; Dose-Response Relationship, Drug; Haloperidol; Humans; Iron; Liver Neoplasms; Niacinamide; Phenylurea Compounds; Piperazines; Receptors, sigma; Sigma-1 Receptor; Sorafenib; Structure-Activity Relationship; Tumor Cells, Cultured | 2017 |
Morphine, haloperidol and hyoscine N-butyl bromide combined in s.c. infusion solutions: compatibility and stability. Evaluation in terminal oncology patients.
Topics: Aged; Aged, 80 and over; Analgesics, Opioid; Antiemetics; Butylscopolammonium Bromide; Chromatography, High Pressure Liquid; Clinical Trials as Topic; Drug Combinations; Drug Stability; Drug Storage; Female; Haloperidol; Humans; Injections, Subcutaneous; Laryngeal Neoplasms; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Morphine; Muscarinic Antagonists; Palliative Care; Retrospective Studies; Time Factors | 2006 |
[Effects of apomorphine and haloperidol on experimental hepatocarcinogenesis].
Topics: Adenoma; Adenoma, Bile Duct; Animals; Apomorphine; Cell Transformation, Neoplastic; Diethylnitrosamine; Haloperidol; Hemangioma; Liver Neoplasms; Liver Neoplasms, Experimental; Male; Neoplasms, Experimental; Rats; Receptors, Dopamine | 1983 |
Intrahepatic Activity Distribution in Radioembolization with Yttrium-90-Labeled Resin Microspheres Using the Body Surface Area Method--A Less than Perfect Model.
Topics: Body Surface Area; Brachytherapy; Computer Simulation; Epoxy Resins; Female; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Models, Biological; Radiometry; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Yttrium Radioisotopes | 2015 |
Bilirubin conjugation by an artificial liver composed of cultured cells and synthetic capillaries.
Topics: Acrylic Resins; Animals; Artificial Organs; Aspartate Aminotransferases; Bilirubin; Capillaries; Carcinoma, Hepatocellular; Cell Line; Cells, Cultured; Cellulose; Epoxy Resins; gamma-Glutamyltransferase; Glucose; L-Lactate Dehydrogenase; Liver; Liver Neoplasms; Nucleotidases; Permeability; Polyurethanes; Rats | 1975 |
Carcinogenic and chronic effects of 4,4'-diaminodiphenylmethane, an epoxyresin hardener.
Topics: Aniline Compounds; Animals; Carcinogens; Carcinoma, Hepatocellular; Epoxy Resins; Hemangioma; Kidney Neoplasms; Liver; Liver Cirrhosis, Experimental; Liver Neoplasms; Male; Neoplasms, Experimental; Rats | 1968 |